These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34060327)

  • 41. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
    Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A highly conserved neutralizing epitope on group 2 influenza A viruses.
    Ekiert DC; Friesen RH; Bhabha G; Kwaks T; Jongeneelen M; Yu W; Ophorst C; Cox F; Korse HJ; Brandenburg B; Vogels R; Brakenhoff JP; Kompier R; Koldijk MH; Cornelissen LA; Poon LL; Peiris M; Koudstaal W; Wilson IA; Goudsmit J
    Science; 2011 Aug; 333(6044):843-50. PubMed ID: 21737702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
    Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.
    Wyrzucki A; Dreyfus C; Kohler I; Steck M; Wilson IA; Hangartner L
    J Virol; 2014 Jun; 88(12):7083-92. PubMed ID: 24719426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
    Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.
    Schmeisser F; Friedman R; Besho J; Lugovtsev V; Soto J; Wang W; Weiss C; Williams O; Xie H; Ye Z; Weir JP
    Influenza Other Respir Viruses; 2013 May; 7(3):480-90. PubMed ID: 23122228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin.
    Du L; Jin L; Zhao G; Sun S; Li J; Yu H; Li Y; Zheng BJ; Liddington RC; Zhou Y; Jiang S
    J Virol; 2013 Feb; 87(4):2215-25. PubMed ID: 23221567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
    Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unique structural solution from a V
    Harshbarger WD; Deming D; Lockbaum GJ; Attatippaholkun N; Kamkaew M; Hou S; Somasundaran M; Wang JP; Finberg RW; Zhu QK; Schiffer CA; Marasco WA
    Nat Commun; 2021 Jan; 12(1):559. PubMed ID: 33495478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigenic Fingerprinting of Antibody Response in Humans following Exposure to Highly Pathogenic H7N7 Avian Influenza Virus: Evidence for Anti-PA-X Antibodies.
    Khurana S; Chung KY; Coyle EM; Meijer A; Golding H
    J Virol; 2016 Oct; 90(20):9383-93. PubMed ID: 27512055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain.
    Krammer F; Palese P
    J Infect Dis; 2019 Apr; 219(Suppl_1):S62-S67. PubMed ID: 30715353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Quest for a Universal Flu Vaccine: Headless HA 2.0.
    Krammer F
    Cell Host Microbe; 2015 Oct; 18(4):395-7. PubMed ID: 26468743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
    Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
    PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.
    Zost SJ; Wu NC; Hensley SE; Wilson IA
    J Infect Dis; 2019 Apr; 219(Suppl_1):S38-S45. PubMed ID: 30535315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans.
    Sun W; Kang DS; Zheng A; Liu STH; Broecker F; Simon V; Krammer F; Palese P
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in "universal" influenza virus antibodies: the rise of a hidden trimeric interface in hemagglutinin globular head.
    Wang Y; Hu D; Wu Y; Ying T
    Front Med; 2020 Apr; 14(2):149-159. PubMed ID: 32239416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin.
    Schneemann A; Speir JA; Tan GS; Khayat R; Ekiert DC; Matsuoka Y; Wilson IA
    J Virol; 2012 Nov; 86(21):11686-97. PubMed ID: 22896619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.
    Brazzoli M; Magini D; Bonci A; Buccato S; Giovani C; Kratzer R; Zurli V; Mangiavacchi S; Casini D; Brito LM; De Gregorio E; Mason PW; Ulmer JB; Geall AJ; Bertholet S
    J Virol; 2016 Jan; 90(1):332-44. PubMed ID: 26468547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and Characterization of a Highly Sensitive NanoLuciferase-Based Immunoprecipitation System for the Detection of Anti-Influenza Virus HA Antibodies.
    Honda T; Gomi S; Yamane D; Yasui F; Yamamoto T; Munakata T; Itoh Y; Ogasawara K; Sanada T; Yamaji K; Yasutomi Y; Tsukiyama-Kohara K; Kohara M
    mSphere; 2021 May; 6(3):. PubMed ID: 33980684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
    He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
    J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.